Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-10

Clinical Trial Update: Tacrolimus for Thrombocytopenia in SS [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for tacrolimus in Sjogren syndrome with other organ involvement across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren Syndrome With Other Organ Involvement | Phase 2, Phase 3 | Status: UNKNOWN